Alexandria Real Estate Equities and Continental Grain Company have backed the first close of the Syngenta-backed agricultural bioprocessing platform's latest round.

US-based bioprocessing technology developer GreenLight Biosciences received $50m from investors including food producer Continental Grain Company on Tuesday to close the first tranche of its latest funding round. Life sciences real estate investment trust Alexandria Real Estate Equities took part in the round, through its Alexandria Venture Investments unit. S2G Ventures, Baird Capital, Blue I/O…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.